Researchers develop new method of precisely targeting cancer lesions while protecting healthy tissues

by Kavli IPMUFigure 1. The radionuclide-encapsulated liposomes, including the focus of the study, a ligand called ethylenedicysteine (EC). Credit: Umeda et alA team of researchers has developed a new

Updated on: January 05,2024

Researchers develop new method of precisely targeting cancer lesions while protecting healthy tissues

by Kavli IPMUFigure 1. The radionuclide-encapsulated liposomes, including the focus of the study, a ligand called ethylenedicysteine (EC). Credit: Umeda et alA team of researchers has developed a new

Updated on:January 05,2024

The way genes are switched on in one-cell embryos may resemble the trigger for cancer

byUniversity of BathGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112023When an embryo is formed, its genes—donated by a fertilizing sperm and egg—are sil

Updated on: December 25,2023

The way genes are switched on in one-cell embryos may resemble the trigger for cancer

byUniversity of BathGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112023When an embryo is formed, its genes—donated by a fertilizing sperm and egg—are sil

Updated on:December 25,2023

Most U.S. children have adequate geographic access to cancer care

by Lori SolomonMost U.S. children and adolescents and young adults (AYAs) have adequate access to pediatric cancer care, according to a study published online Jan. 19 inJAMA Network Open.Xiaohui

Updated on: December 20,2023

Most U.S. children have adequate geographic access to cancer care

by Lori SolomonMost U.S. children and adolescents and young adults (AYAs) have adequate access to pediatric cancer care, according to a study published online Jan. 19 inJAMA Network Open.Xiaohui

Updated on:December 20,2023

Patients with high-risk melanoma had better quality of life on pembrolizumab than on standard immunotherapy regimens

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainPatients with high-risk stage III-IV melanoma who received pembrolizumab after their surgery reported a better quality of life than pati

Updated on: December 22,2023

Patients with high-risk melanoma had better quality of life on pembrolizumab than on standard immunotherapy regimens

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainPatients with high-risk stage III-IV melanoma who received pembrolizumab after their surgery reported a better quality of life than pati

Updated on:December 22,2023

Cancer biology: Some cancer cells can lose their capability to migrate

Updated on: December 18,2023

Cancer biology: Some cancer cells can lose their capability to migrate

Updated on:December 18,2023

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.

Updated on: April 28,2024

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.

Updated on:April 28,2024

Public insurance tied to lower cancer survival in young patients

(HealthDay)—Young, low-income patients with bone or soft tissue sarcomas have decreased overall survival (OS), regardless of disease stage at presentation, according to a study published online Dec. 1

Updated on: December 22,2023

Public insurance tied to lower cancer survival in young patients

(HealthDay)—Young, low-income patients with bone or soft tissue sarcomas have decreased overall survival (OS), regardless of disease stage at presentation, according to a study published online Dec. 1

Updated on:December 22,2023

Exploiting the synergy of nutraceuticals for cancer prevention and treatment

by Cactus CommunicationsResearchers from Tata Memorial Centre, India, demonstrate how a resveratrol-copper mix inactivates cell-free chromatic particles to ameliorate a host of pathologies, including

Updated on: December 28,2023

Exploiting the synergy of nutraceuticals for cancer prevention and treatment

by Cactus CommunicationsResearchers from Tata Memorial Centre, India, demonstrate how a resveratrol-copper mix inactivates cell-free chromatic particles to ameliorate a host of pathologies, including

Updated on:December 28,2023

Neoantigen DNA vaccine shows promise against aggressive breast cancer in clinical trial

by Julia Evangelou Strait,Washington University School of MedicineA small clinical trial conducted at WashU Medicine shows promising results for patients with triple-negative breast cancer who r

Updated on: December 02,2024

Neoantigen DNA vaccine shows promise against aggressive breast cancer in clinical trial

by Julia Evangelou Strait,Washington University School of MedicineA small clinical trial conducted at WashU Medicine shows promising results for patients with triple-negative breast cancer who r

Updated on:December 02,2024

More women need to be screened for cervical cancer

by Lesley Young,University of AlbertaCredit: CC0 Public DomainUp to 30 per cent of Canadian women are not being regularly screened for cervical cancer, and the lapse is resulting in unnecessary

Updated on: December 18,2023

More women need to be screened for cervical cancer

by Lesley Young,University of AlbertaCredit: CC0 Public DomainUp to 30 per cent of Canadian women are not being regularly screened for cervical cancer, and the lapse is resulting in unnecessary

Updated on:December 18,2023

'Olive oil' drug shows early promise for some brain cancer patients

by Institute of Cancer ResearchMechanism of action of 2-OHOA. (1) 2-OHOA regulates the cell membrane composition by both direct incorporation into the lipid bilayer and regulation of important li

Updated on: April 02,2024

'Olive oil' drug shows early promise for some brain cancer patients

by Institute of Cancer ResearchMechanism of action of 2-OHOA. (1) 2-OHOA regulates the cell membrane composition by both direct incorporation into the lipid bilayer and regulation of important li

Updated on:April 02,2024

New targets in the fight against pancreatic cancer

by Tokyo Medical and Dental UniversityTop, SETD1A, directly recruited to the RUVBL1 promoter, enhances RUVBL1 gene expression by increasing H3K4me3 levels in pancreatic cancer cells. Bottom, High co-e

Updated on: December 27,2023

New targets in the fight against pancreatic cancer

by Tokyo Medical and Dental UniversityTop, SETD1A, directly recruited to the RUVBL1 promoter, enhances RUVBL1 gene expression by increasing H3K4me3 levels in pancreatic cancer cells. Bottom, High co-e

Updated on:December 27,2023